[1]徐 晶,王思文,孙玉婷,等.2018-2022年国外肿瘤学期刊研究热点分析[J].医学信息,2024,37(12):35-39.[doi:10.3969/j.issn.1006-1959.2024.12.007]
 XU Jing,WANG Si-wen,SUN Yu-ting,et al.Analysis of Research Hotspots in Foreign Oncology Journals from 2018 to 2022[J].Journal of Medical Information,2024,37(12):35-39.[doi:10.3969/j.issn.1006-1959.2024.12.007]
点击复制

2018-2022年国外肿瘤学期刊研究热点分析()

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年12期
页码:
35-39
栏目:
出版信息学
出版日期:
2024-06-15

文章信息/Info

Title:
Analysis of Research Hotspots in Foreign Oncology Journals from 2018 to 2022
文章编号:
1006-1959(2024)11-0035-05
作者:
徐 晶王思文孙玉婷
(中华预防医学会,北京 100062)
Author(s):
XU JingWANG Si-wenSUN Yu-tinget al.
(Chinese Preventive Medicine Association,Beijing 100062,China)
关键词:
肿瘤学关键词研究热点期刊
Keywords:
OncologyKeywordsResearch hotspotsJournals
分类号:
R73
DOI:
10.3969/j.issn.1006-1959.2024.12.007
文献标志码:
A
摘要:
目的 分析2018-2022年国外肿瘤相关期刊发布的高被引论文关键词,揭示肿瘤疾病领域的研究热点,为肿瘤领域相关研究者提供数据支持。方法 选取在JCR学科分类中肿瘤学(Oncology)学科下的所有期刊,按2021年影响因子排序,取排名前20位的期刊,分析每本期刊高被引前50篇文章的关键词出现频次及其相关作者数和期刊数。结果 20本期刊中有11本被引频次超过10 000次,其中CA: A Cancer Journal for Clinicians杂志被引次数最多,达133 920次;关键词(组)以“生存”出现频次最多,达107次,总被引频次最高,达65 574次,相关作者数最多为1925人,文献数也最多达124篇。肿瘤患者生存、免疫抑制剂相关作者数均超过1000人;肿瘤患者生存、免疫抑制剂、肿瘤标志物领域关键词均出现在20本期刊。结论 肿瘤患者生存、免疫抑制剂、肿瘤微环境、标记物是该领域研究热点。各期刊高频关键词的出现次数、总被引频次、文献数排序基本一致。通过高频词关键词(组)的呈现,为肿瘤研究提供了方向。
Abstract:
Objective To analyze the keywords of highly cited papers published in foreign tumor-related journals from 2018 to 2022, reveal the research hotspots in the field of tumor diseases, and provide data support for researchers in the field of tumor.Methods All journals in the subject category of Oncology in Journal Citation Reports (JCR) were ranked according to 2021 impact factor, and the top 20 journals were selected. From each journal, the 50 top-cited papers were retrieved, of which the keywords were grouped and analyzed in terms of frequency, the number of related authors and the number of selected journals in which the keywords appeared.Results Among the 20 journals, 11 were cited more than 10 000 times, among which CA: A Cancer Journal for Clinicians topped with 133 920 citations. The keyword group about "survival" was the most common among all the analyzed keyword groups, which appeared for 107 times; the related papers were cited 65 574 times; the number authors of the related papers was the highest with 1925 authors; and the number of papers listing survival-related keywords (124 articles) was also larger than that for any other keyword groups. For all the top-cited papers, more than 1000 authors used keyword related to survival of cancer patients or immunosuppressants. Keyword groups related to cancer patient survival, immunosuppressants, and tumor markers were found in all the 20 journals.Conclusion The survival of cancer patients, immunosuppressants, tumor microenvironment, and tumor markers are the research hotspots in the field of tumor. The frequency, total citation frequency, and the ranking of related articles of high-frequency keywords are generally constant across oncology journals. The distribution of high-frequency keywords (groups) provides direction for future cancer research.

参考文献/References:

[1]Siegel RL,Miller KD,Hannah E,et al.Cancerstatistics[J].CA Cancer J Clin,2022,72(1):7-33.[2]韩雪娇,李雪梅,龚小清,等.肿瘤领域全球研究热点——基于ESI热点论文的计量分析[J].生物医学工程学杂志,2020,37(6):1012-1024.[3]高劲松,黄梅,付家炜.基于年度高频关键词的研究热点提取与可视化研究[J].现代情报,2020,40(12):130-139.[4]金星,武颖.基于关键词共词分析的心理因素与癌症关系研究热点及趋势的可视化研究[J].中国药物与临床,2020,20(7):1061-1063.[5]金花,付强强,于德华.2001—2020年中国全科医学与社区卫生研究热点及趋势分析[J].中国全科医学,2022,25(34):4241-4251.[6]奉国和,孔泳欣.基于时间加权关键词词频分析的学科热点研究[J].情报学报,2020,39(1):100-110.[7]刘智锋,李信.作者关键词生存分析——以国内图情领域为例[J].图书馆杂志,2020,39(7):48-57.[8]李海林,万校基,林春培.基于关键词重要性和近邻传播聚类的主题分析研究[J].情报学报,2018,37(5):533-542.[9]李轩,王子为,赵靖萱,等.肿瘤预后预测领域机器学习应用的文献计量与热点可视化分析[J].医学信息,2022,35(9):90-94.[10]曹士佳,张建亭,曹宇,等.2014-2018年肿瘤护理相关文献计量学及可视化分析[J].现代肿瘤医学,2020,28(16):2886-2890.[11]肖纯,李文雅,刘娅健,等.基于CiteSpace的肿瘤患者中医护理研究热点及发展趋势分析[J].中国医药导报,2021,18(33):156-160.[12]张学应,王飞龙,邬敏,等.基于PubMed数据库肿瘤治疗电场研究热点的共词聚类分析[J].海南医学,2021,32(12):1511-1515.[13]杨智慧,缪景霞,廖荣荣,等.肿瘤免疫治疗护理相关研究的关键词可视化分析[J].护理学报,2023,30(1):12-16.[14]余丰民,林彦汝.基于关键词词频统计的学科研究热点漂移程度模型构建及实证分析[J].情报理论与实践,2020,43(2):100-105.[15]卢新元,张恒,王馨悦,等.基于科学计量学的国内企业知识转移研究热点和前沿分析[J].情报科学,2019,37(3):169-176.[16]任公卿,姚静.抗CTLA-4和PD-1免疫疗法在肿瘤治疗中的应用[J].济宁医学院学报,2021,44(5):356-361.[17]Takahashi A,Namikawa K,Ogata D,et al.Real-world efficacy and safety data of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma[J].J Dermatol,2020,47(11):1267-1275.[18]郝毅.下调Tetraspanin 8抑制三阴乳腺癌细胞PD-L1表达增强抗肿瘤免疫反应[J].中国实验诊断学,2021,25(7):1061-1065.[19]Wang L,Yang R,Zhao L,et al.Basing on uPAR-binding fragment to design chimeric antigen receptors triggers antitumor efficacy against uPAR expressing ovarian cancer cells[J].Biomed Pharmacother,2019,117:109173-109181.[20]吕鑫,张翊玲,姚红梅.基于知识图谱分析肿瘤标志物在肺癌中应用的研究热点、方向及趋势[J].山东医药,2020,60(12):1-4.[21]Hatano K,Fujiwara SI,Umino K,et al.Clinical interactionbetween dexamethasone and aprepitant in chemotherapy forlymphoma[J].Annals of Hematology,2022,101(6):1211-1216.[22]Wedgwood S,Gerard K,Halloran K,et al.Intestinaldysbiosis and the developing lung:the role of Toll-like receptor 4 in thegut-lung axis[J].Front Immunol,2020,11:357.[23]Mehrian-Shai R,Reichardt JKV,Harris CC,et al.The Gut-Brain Axis, Paving the Way to Brain Cancer[J].Trends Cancer,2019,5(4):200-207.[24]Di Modica M,Gargari G,Regondi V,et al.Gut microbiotacondition the therapeutic efficacy of trastuzumab in HER2-positive breastcancer[J].Cancer Res,2021,81(8):2195-2206.[25]Matsushita M,Fujita K,Hayashi T,et al.Gut microbiota-derived short-chain fatty acids promote prostate cancer growth via IGF1signaling[J].Cancer Res,2021,81(15):4014-4026.[26]王玲玲.基于文献计量视角的近10年ESI高被引论文分析——以肿瘤学为例[J].江苏科技信息,2022,39(1):1-3.

相似文献/References:

[1]陈怡东.肿瘤学专业临床型博士研究生的培养研究[J].医学信息,2018,31(15):3.[doi:10.3969/j.issn.1006-1959.2018.15.002]
 CHEN Yi-dong.Cultivation of Clinical Doctoral Students in Oncology[J].Journal of Medical Information,2018,31(12):3.[doi:10.3969/j.issn.1006-1959.2018.15.002]
[2]吴 申,吴孝雄.从金元医家的发展探讨中医肿瘤理论的发展[J].医学信息,2020,33(20):149.[doi:10.3969/j.issn.1006-1959.2020.20.046]
[3]姚文亿,吴孝雄.癌邪理论学术思想指导清肝祛癌方治疗肝癌的应用[J].医学信息,2021,34(21):159.[doi:10.3969/j.issn.1006-1959.2021.21.045]

更新日期/Last Update: 1900-01-01